Revolution Medicines' Mancini Sells Shares, Buys Others at Lower Price

Revolution Medicines, Inc. [RVMD] announced that Chief Global Commercialization Officer Anthony Mancini has recently engaged in a series of transactions involving the company's shares. Specifically, on March 25, 2026, Mancini sold 11,036 shares at a price of $96.43 per share, and also sold 400 shares at $97.21 per share on the same day. In addition, he purchased 37,450 shares at $33.62 per share, and sold 1,800 shares at $93.22 per share, as well as 3,128 shares at $94.16 per share and 21,086 shares at $95.49 per share. These transactions were all made on March 25, 2026.